Maxime Dely: Guillain-Barré Syndrome – What if the Key Lies in the Plasma?
Maxime Dely, Therapeutic Solutions Sales Consultant at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
“Guillain-Barré syndrome: what if the key lies in the plasma?
Guillain-Barré syndrome is an acute inflammatory neuropathy in which autoimmune mechanisms target the peripheral nervous system. Depending on the subtype, autoantibodies, immune complexes, and inflammatory mediators contribute to axonal or demyelinating injury.
This is where therapeutic plasma exchange becomes particularly relevant.
Through blood component separation, notably by centrifugation, apheresis enables the removal of a significant fraction of the patient’s plasma, which is then replaced with an appropriate substitution fluid.
The objective: achieve high plasma clearance within a limited number of sessions, rapidly reducing the concentration of circulating pathogenic factors.
This is the strength of apheresis: directly targeting the biological compartment that carries key mediators of the pathological immune response.
A separation technology that becomes a genuine therapeutic tool.
And behind every extracorporeal circuit, there is ultimately one goal: buying time when every hour matters.”
Other posts featuring Maxime Dely on Hemostasis Today.
-
Oct 26, 2026, 03:43Shazmah Shaikh: How Laser Atherectomy Helps Clear Blocked Arteries
-
Oct 26, 2026, 03:28Priya Prasad: Protecting Donors and Recipients Through Blood Safety
-
Oct 25, 2026, 19:55Giacomo Buso: LIPLEG Provides the Strongest Evidence to Date on Lipedema Treatment
-
Oct 25, 2026, 19:54Nicholas Lee: ASH Program Connects Trainees and Faculty With Mentors for Career Development
-
Oct 25, 2026, 19:53World Thrombosis Day Raises Blood Clot Awareness at Italian Airports
-
Oct 25, 2026, 19:49Tahsim Anwar: A Six-Year Analysis of Adverse Events in Therapeutic Apheresis
-
Oct 25, 2026, 19:37William Wallace: More than 1 in 3 People with Parkinson’s Were Low in B6
-
Oct 25, 2026, 19:36Andrés Felipe Escobar González: Individualized Treatment Strategies for HMB in BDUC
-
Oct 25, 2026, 19:34Christophe Nougier: Returning to Burundi for the WFH-Supported Twinning Project